e8vk
 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 6, 2009
Cardiovascular Systems, Inc.
(Exact name of Registrant as Specified in its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
     
000-52082
(Commission File Number) 		  41-1698056
(IRS Employer
Identification No.)
651 Campus Drive
St. Paul, Minnesota 55112-3495
(Address of Principal Executive Offices and Zip Code)
(651) 259-1600
(Registrant’s telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

Item 2.02 Results of Operations and Financial Condition.
On May 6, 2009, Cardiovascular Systems, Inc. held a conference call to discuss the company’s financial results for the third fiscal quarter ended March 31, 2009. A transcript of the call is furnished herewith as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
     
Exhibit Number   Description
   
99.1
  Cardiovascular Systems, Inc. transcript from the conference call held on May 6, 2009, with respect to its financial results for the third fiscal quarter ended March 31, 2009.

 

 

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 12, 2009
         
  CARDIOVASCULAR SYSTEMS, INC.
 		  
  By:   /s/ Laurence L. Betterley    
    Laurence L. Betterley   
    Chief Financial Officer   
 

 

 

EXHIBIT INDEX
     
Exhibit Number   Description
   
99.1
  Cardiovascular Systems, Inc. transcript from the conference call held on May 6, 2009, with respect to its financial results for the third fiscal quarter ended March 31, 2009.